Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Stayble Therapeutics AB

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 52 More Arrow 238 Less Arrow 28
Earnings before taxes -12,418 Less Arrow -23,737 Less Arrow -24,526
EBITDA -12,646 Less Arrow -23,954 Less Arrow -24,796
Total assets 9,257 More Arrow 21,703 Less Arrow 19,148
Current assets 3,608 More Arrow 16,053 Less Arrow 13,498
Current liabilities 1,535 More Arrow 4,345 Less Arrow 3,016
Equity capital 6,872 More Arrow 16,508 Less Arrow 15,282
- share capital 5,684 Less Arrow 4,124 Less Arrow 1,800
Employees (average) 2 More Arrow 3 Equal arrow 3

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 74.2% More Arrow 76.1% More Arrow 79.8%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -133.6% More Arrow -108.3% Less Arrow -127.9%
Current ratio 235.0% More Arrow 369.5% More Arrow 447.5%
Return on equity (ROE) -180.7% More Arrow -143.8% Less Arrow -160.5%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -1 More Arrow 0 Equal arrow 0
Chg. No. of employees % -33% More Arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.